Baxter International

BAX Net selling

CIK 0000010456 #65 in the set updated 17 Sep 2026

Bought (120 mo)

$803.82K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$1.93B

$0.00 on a plan · $85.20M straight out of an exercise

Sold at will

$1.85B

18 of 102 sales

Net

−$1.93B

−$1.85B against sales at will

By person

52 insiders · 104 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Third Point LLC entity

Director

—

$1.85B (5)

−$1.85B

23,008,125

$934.36M

−55.7%

Mason Jeanne K

EVP, Chief HR Officer

—

$21.39M (9) scheduled

−$21.39M

199,853

$8.12M

+104.2%

Eyre Brik V

SVP, President, Americas

—

$19.05M (5) scheduled

−$19.05M

77,998

$3.17M

+92.2%

Accogli Giuseppe

EVP, Chief Operating Officer

—

$13.14M (5) scheduled

−$13.14M

130,805

$5.31M

+63.5%

Martin Sean

SVP and General Counsel

$803.82K (1)

$6.93M (5) scheduled

−$6.13M

52,632

$2.14M

+4,225%

Franzi Cristiano

SVP, President, EMEA

—

$4.08M (2) scheduled

−$4.08M

102,145

$4.15M

+4,100%

Pleau Scott

SVP, Operations

—

$3.58M (3) scheduled

−$3.58M

20,076

$815.29K

−1.9%

GAVIN JAMES R III

Director

—

$3.42M (6) scheduled

−$3.42M

39,508

$1.60M

+23.7%

STORM KORNELIS J.

Director

—

$3.30M (3) scheduled

−$3.30M

22,512

$914.21K

+7.0%

Shapazian Carole J

Director

—

$3.09M (9) scheduled

−$3.09M

9,848

$399.93K

+6.7%

STROUCKEN ALBERT P L

Director

—

$2.15M (10) scheduled

−$2.15M

69,800

$2.83M

+28.4%

HELLMAN PETER S

Director

—

$1.99M (9) scheduled

−$1.99M

30,335

$1.23M

+34.5%

FORSYTH JOHN D

Director

—

$1.76M (13) scheduled

−$1.76M

27,029

$1.10M

−3.9%

STALLKAMP THOMAS T

Director

—

$1.73M (9) scheduled

−$1.73M

11,576

$470.10K

−5.7%

Frye Andrew

SVP, President, APAC

—

$1.57M (3)

−$1.57M

22,002

$893.50K

+3,269%

Kunzler Jacqueline

SVP, Chief Quality Officer

—

$725.04K (3)

−$725.04K

22,625

$918.80K

+264.2%

Stevens Brian

SVP, CAO & Controller

—

$213.76K (2)

−$213.76K

67,538

$2.74M

+2,988%

Chen Thomas F

Director

—

$142.01K (1) scheduled

−$142.01K

15,740

$639.20K

+865.6%

Hider Andrew P.

President and CEO

—

—

—

518,447

$21.05M

+17,971%

Grade Joel T.

EVP and CFO

—

—

—

271,674

$11.03M

+3,989%

ALMEIDA JOSE E

Chairman, CEO, President

—

—

—

243,589

$9.89M

—

SACCARO JAMES

EVP, Chief Financial Officer

—

—

—

177,899

$7.22M

+289.7%

Knight Heather

EVP, Chief Operating Officer

—

—

—

177,362

$7.20M

+340.7%

Rosenbloom David S.

EVP and General Counsel

—

—

—

138,216

$5.61M

+1,971%

Sonig Alok

EVP,Group President,Pharma

—

—

—

128,219

$5.21M

+472.8%

Rasul Reazur

EVP,Group Pres,Healthcare

—

—

—

125,557

$5.10M

+624.5%

Scharf David P.

CVP and General Counsel

—

—

—

109,789

$4.46M

+15.5%

Toth Christopher A.

EVP, Group Pres, Kidney Care

—

—

—

105,186

$4.27M

—

Soriano Maria Cecilia

Group Pres., ITT & Pharma.

—

—

—

75,045

$3.05M

+37.3%

Shafer David Brent

Director

—

—

—

72,804

$2.96M

+3,522%

Borzi James W

EVP,Chief Supply Chain Officer

—

—

—

71,948

$2.92M

+1,982%

Wallace Steven P.

President, Adv. Surgery

—

—

—

70,128

$2.85M

−0.2%

Zielinski Anita A

SVP, Interim CFO, CAO & Cntrlr

—

—

—

59,714

$2.42M

+25,528%

Vibert Paul

CVP, International

—

—

—

51,283

$2.08M

+10.6%

Wendell Amy McBride

Director

—

—

—

44,235

$1.80M

+687.1%

MORRISON PATRICIA

Director

—

—

—

42,386

$1.72M

+2,187%

Wilkes David S.

Director

—

—

—

37,076

$1.51M

+2,914%

Oesterle Stephen N.

Director

—

—

—

35,847

$1.46M

+1,481%

Schabacker Marcus

CVP, Chief Scientific Officer

—

—

—

35,602

$1.45M

+17.6%

SCHLICHTING NANCY M

Director

—

—

—

34,994

$1.42M

+3,396%

Flynn Steven

SVP, President, APAC

—

—

—

31,080

$1.26M

+157.9%

Ampofo William A. II

Director

—

—

—

30,375

$1.23M

+5,022%

Teaff James

President, CCS

—

—

—

30,370

$1.23M

−3.4%

Smith Cathy R

Director

—

—

—

30,345

$1.23M

+1,751%

Carlisle Cynthia

Executive Vice President, CHRO

—

—

—

29,677

$1.21M

—

Foster Julie

President, Front Line Care

—

—

—

29,164

$1.18M

−6.7%

Craig Jeffrey A

Director

—

—

—

23,662

$960.91K

+13,737%

RUSCKOWSKI STEPHEN H

Director

—

—

—

16,499

$670.02K

+5,138%

McDonnell Michael R.

Director

—

—

—

14,647

$594.81K

—

WILVER PETER M

Director

—

—

—

13,267

$538.77K

+4,983%

Karp Caroline

SVP, Controller

—

—

—

12,557

$509.94K

+9.3%

Mahoney Michael F

Director

—

—

—

9,692

$393.59K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

1

Insider

Date

Role

Action

Shares

Price

Amount

Martin Sean

30 Mar 2020

SVP and General Counsel

Buy

9,780

$82.19

$803.82K

Show all 104 transactions →

What was left out

Form 4 filings counted 518

Amendments (4/A) skipped 1

Filings about a different issuer 1

Unreadable filings 0

Joint filings 5

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 84

Sales at will 18

Transactions with no price 0

Shares from compensation/vesting 6,194,593

Sales filed before the plan box existed 18

History held since 30 Aug 2016